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Summary
Visual deprivation is a classical tool to study the plas-
ticity of visual cortical connections. After eyelid clo-
sure in young animals (monocular deprivation, MD),
visual cortical neurons become dominated by the
open eye, a phenomenon known as ocular dominance
(OD) plasticity [1]. It is commonly held that the molec-
ular mediators of OD plasticity are cortically derived
and that the retina is immune to the effects of MD [2–
4]. Recently, it has been reported that visual depriva-
tion induces neurochemical, structural, and functional
changes in the retina [5–7], but whether these retinal
changes contribute to the effects of MD in the cortex
is unknown. Here, we provide evidence that brain-
derived neurotrophic factor (BDNF) produced in the
retina influences OD plasticity. We found a reduction
of BDNF expression in the deprived retina of young
rats. We compensated this BDNF imbalance between
the two eyes by either injecting exogenous BDNF in
the deprived eye or reducing endogenous BDNF ex-
pression in the nondeprived eye. Both treatments
were effective in counteracting the OD shift induced
by MD. Retinal BDNF could also influence OD distribu-
tion in normal animals. These results show for the first
time that OD plasticity is modulated by BDNF pro-
duced in the retina.
Results
It is known that the expression of BDNF in the retina is
dependent on visual input [6, 7]. Recently, we and others
have demonstrated that both endogenous and exoge-
nous BDNF is transported anterogradely by retinal gan-
glion cells (RGCs) and released to geniculocortical cells
[8–10]. The activity-dependent expression of BDNF and
its anterograde trafficking prompted us to investigate
*Correspondence: g.mandolesi@hsantalucia.it
5 Present address: Department of Medical Pharmacology, C.N.R.
Institute of Neuroscience and University of Milan, Via Vanvitelli 32,
20129 Milano, Italy.whether retina-derived BDNF might play a role in OD
plasticity.
First, we assessed whether a brief period of MD at
postnatal day 22–23 (P22–P23) modulates BDNF ex-
pression in the retina. Rats were monocularly deprived
for one week, and retinal BDNF levels were measured
by the enzyme-linked immunoadsorbent assay (ELISA).
We observed a consistent reduction of BDNF con-
centration in the retinas dissected from deprived eyes
with respect to control conditions. The mean BDNF con-
centration in retinas of deprived eyes was 3.58 6 0.27
(S.E.) pg/mg of proteins, whereas in the retinas dis-
sected from the open eyes, it was 6.36 6 0.28 (S.E.)
pg/mg. In normal animals, the mean concentration was
6.69 6 0.44 (S.E.) pg/mg total protein (one-way ANOVA,
p < 0.001; post hoc Tukey test, deprived versus open
eye, p < 0.05) (Figure 1).
The finding of a decreased BDNF expression in the
deprived retina led us to investigate whether a compen-
sation of BDNF imbalance between the two eyes could
affect the shift in cortical OD after a period of monocular
occlusion. We modulated the levels of BDNF expression
in the retina by using two complementary strategies. In
a group of monocularly sutured animals, we increased
BDNF availability to the deprived eye by intravitreally in-
jecting recombinant BDNF. As shown in Figures 1B–1C,
exogenous BDNF is efficiently taken up by the retina and
transported to the lateral geniculate nucleus with a max-
imal accumulation at 48 hr after injection. In a second set
of experiments, we decreased BDNF expression in the
nondeprived eye by injecting antisense oligonucleotides
against BDNF. This antisense strategy is very efficient in
suppressing BDNF protein levels in the retina and BDNF
anterograde transport (Figures 1D–1E and [9]). Our data
demonstrate that either exogenous BDNF administra-
tion to the deprived eye or reduction of BDNF levels in
the open eye impair the expected OD shift in the cortex.
Exogenous Supply of BDNF into the Deprived
Eye Prevents MD Effects
6 hr before eyelid suture, P22–P23 rats (n = 6) were in-
jected with 10 mg of recombinant human BDNF. After
3–4 days of MD, we performed extracellular recordings
of single-unit activity in the primary visual cortex contra-
lateral to the deprived eye to assess the OD of visual cor-
tical neurons. We found that 3–4 days of MD in our con-
trol animals (n = 5, MD control) were sufficient to induce
a shift of OD distribution toward the open eye (Figure 2A),
as it has been shown previously [11]. In contrast, a single
intravitreal injection of BDNF counteracted the MD ef-
fects on the OD distribution (c2 test, MD + BDNF versus
MD control, p < 0.001) (Figure 2B). The OD distributions
of all animals in each group are summarized in Figure 2D
by showing the contralateral bias index (CBI), in which
0 represents complete ipsilateral dominance, and 1 indi-
cates complete contralateral dominance. The means of
the CBIs calculated for animals treated with exogenous
BDNF (0.50 6 0.019) and for the MD control group
(0.36 6 0.013) were found to be significantly different
(t test, p < 0.001). An alternative and finer comparison
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Figure 1. Modulation of Retinal BDNF Levels and BDNF Antero-
grade Transport
(A) Retinal BDNF expression is reduced in monocularly deprived an-
imals. BDNF protein levels were determined by ELISA, and the con-
centration of BDNF protein is shown in picogram BDNF per miligram
total protein. Retinas were dissected from deprived (MD, n = 4 sam-
ples of 14 retinas each) and nondeprived eyes (CTR, n = 4 samples
of 14 retinas each) of animals monocularly deprived for one week
and from animals reared with normal visual experience (norm, n =
3 samples of 15 retinas each). Solid symbols are mean 6 S.E. The
concentration of BDNF in deprived retinas is significantly reduced
with respect to both nondeprived and normal retinas (one-way
ANOVA, p < 0.001; post hoc Tukey test, p < 0.05). The experiment
was repeated three times with different sets of samples and gave
identical results.
(B and C) Measurements of radiolabeled BDNF in the eye (B) and
geniculate (C) of P21 rats by g counting after intraocular injection
of 500 ng radiolabeled BDNF. Data points are from individual ani-
mals or represent the average from two independent experiments.
(B) shows retention of BDNF in the injected right eye (black dots)
compared with amounts of radiolabeled BDNF in the contralateral
(left) eye (open circles). The levels of exogenous BDNF in the eye
dropped from about 150 ng at 6 hr to about 70 ng at 24 hr and about
15 ng at 96 hr. Approximately half of the total amount in the eye
was present within the retina (data not shown). (C) shows accumu-
lation of radiolabeled BDNF in the left (black dots) and right
(control) lateral geniculate nucleus (dLGN) after injection in the right
eye.
(D and E) Intraocular injection of antisense, but not sense, oligonu-
cleotides against BDNF abrogates BDNF anterograde transport.
Longitudinal optic nerve sections from P24 rats which received
an intravitreal injection of sense (D) or antisense oligonucleotides
(E) and whose optic nerves were crushed. Immunostaining for
BDNF shows BDNF accumulation at the proximal site of the crush
in the sense-treated animal (D) but not in the antisense-treated one
(E). The scale bar represents 100 mm.of the OD distributions was provided by the compu-
tation of the OD score for all cells recorded in BDNF-
treated and control MD animals [11, 12]. The cumulative
distribution of the OD score in BDNF-treated animals
was statistically different with respect to that in MD con-
trol animals (Kolmogorov-Smirnov [K-S] test, p < 0.001)
(Figure 2E).
Reduction of BDNF Expression in the Nondeprived
Eye Prevents MD Effects
We decreased BDNF expression in the nondeprived eye
by injecting antisense oligonucleotides, which prevent
translation of BDNF mRNA. Intraocular injections of an-
tisense oligonucleotides against BDNF were performed
every 48 hr in the nondeprived eye of P22 rats (n = 7)
starting at the time of MD. Sense oligonucleotides
were injected with the same time schedule and used
as controls (n = 5, MD control). After 3–4 days, we re-
corded single-unit activity in the visual cortex contralat-
eral to the deprived eye. Inhibition of BDNF expression
in the retina by the antisense oligonucleotides almost
completely prevented the effects of MD on the OD distri-
bution as shown in Figure 2C (c2 test, MD + antisense
versus MD control, p < 0.001). The mean CBI value and
the cumulative distribution of the OD score derived
from the MD + antisense rats were significantly different
from those of MD control animals (Mann-Whitney rank
sum test, p = 0.005, and K-S test, p < 0.001, respec-
tively), but they were superimposable to those of MD
rats treated with exogenous BDNF (Mann-Whitney
rank sum test, p > 0.05, and K-S test, p > 0.05) (Figures
2D and 2E). Altogether, these data show that compen-
sating the imbalance of BDNF in the retina prevents
the OD shift in MD rats.
An Imbalance of BDNF between the Two Eyes Shifts
OD in Rats Reared with Normal Visual Experience
We next asked whether manipulating retinal BDNF lev-
els could shift the normal OD of cortical neurons. To ad-
dress this question, we injected exogenous BDNF into
one eye and antisense oligonucleotides for BDNF into
the other eye in animals reared with normal visual expe-
rience. This protocol was chosen to maximize BDNF
imbalance between the two eyes. The injections were
repeated every 48 hr starting at P22–P23, and after
1 week, we assessed OD in the cortex ipsilateral to the
BDNF-treated eye (n = 4 animals). To control for possible
changes in eye preference because of physical damage
or oligonucleotide delivery to the eye, we subjected
seven animals to monocular, repeated intravitreal injec-
tions of sense oligonucleotides over a 7 day period. We
found that repetitive injections of the sense oligonucleo-
tides did not induce changes in OD. Indeed, the CBIs
values in the sense group were identical to those in
normal untreated animals (Figure 3A) (t test, p = 0.99).
Conversely, exogenous supply of BDNF into one eye
combined with antisense treatment of the other eye
resulted in a consistent OD shift as demonstrated by
statistical analysis of the CBI values (t test, p < 0.001)
(Figure 3A) and of the cumulative distributions of the
OD score (K-S test, p < 0.001) (Figure 3B). These data in-
dicate that a modulation of retinal BDNF levels can influ-
ence the normal OD distribution in visual cortex.
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Figure 2. Retinal BDNF Affects the OD Shift
Induced by MD
(A, B, and C) OD distributions of rats (P27–
P28) monocularly deprived (MD) for 3–4 days
and injected with: (A) sense oligonucleotides
in the nondeprived eye (indicated by the ar-
row) (dark gray bars, n = 5 rats, 151 cells)—
the light gray bars represent the OD distribu-
tion of animals reared with normal visual ex-
perience (n = 6 rats, 217 cells); (B) exogenous
BDNF in the deprived eye (indicated by the ar-
row) (n = 6 rats, 187 cells); and (C) antisense
oligonucleotides for BDNF in the nondeprived
eye (indicated by the arrow) (n = 7 rats, 204
cells). The OD distributions of MD + BDNF
and MD + antisense rats differ significantly
from that of MD control rats (c2 test, p < 0.001).
(D) CBIs of all treated animals. Triangles rep-
resent mean CBI 6 S.E.; each circle repre-
sents CBI of a single animal. The CBIs of MD
+ antisense and MD + BDNF rats are statisti-
cally different from those of MD control rats
(Kruskal-Wallis one-way ANOVA, p = 0.008;
post hoc Dunn’s test, p < 0.05). Shaded region
represents the CBI range of normal animals.
(E) Cumulative distribution of the OD score in
each experimental group. Statistical compar-
ison of the cumulative distributions of the
OD score confirms that either antisense or
BDNF treatment prevents MD effects (K-S
test, p < 0.001).Manipulation of BDNF Expression in the Retina
Does Not Affect Visual Responses of Retinal
Ganglion Cells and Geniculate Neurons
It might be argued that the effects of retinal BDNF on
cortical OD are secondary to an alteration of neural ac-
tivity in the afferent pathway to the cortex. To address
this issue, we analyzed RGC spiking activity by extracel-
lular recordings from the optic tract contralateral to the
injected eye in a subset of antisense-, sense-, or exoge-
nous BDNF-treated rats (n = 5–8 animals per group).
BDNF-treated rats were analyzed either within 2 hr (to
assess acute effects of BDNF on RGC activity) or 1–2
days after a single intravitreal injection of the neurotro-
phin. The injections of antisense oligonucleotides (or
sense oligonucleotides as control) were repeated after
48 hr, and recordings were performed 3–4 days afterbeginning of the treatment. We found that the rate of
spontaneous discharge of RGCs was undistinguishable
between normal rats and rats receiving BDNF, anti-
sense, or sense treatment (one-way ANOVA on ranks,
p = 0.10) (Figures 4A and 4B). Responses to light were
also similar among the groups (one-way ANOVA on
ranks, p > 0.05) (Figures 4A and 4C).
Because BDNF is anterogradely transported, it might
also affect electrical activity at the geniculate level. Ac-
cordingly, we also performed single-unit recordings
from the geniculate contralateral to the injected eye in
rats of the various experimental groups. To quantify
cell responsiveness to visual stimulation, we computed
for each geniculate cell the peak-to-baseline ratio, i.e.,
the ratio between peak firing rate in response to an op-
timal stimulus (a light bar drifting into the receptive fieldBA
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Figure 3. Retinal BDNF Influences the OD
Distribution of Animals Reared with Normal
Visual Experience
(A) CBIs of normally reared rats that received
monocular injections of sense oligonucleoti-
des (sense) or injections of exogenous BDNF
into one eye and antisense oligonucleotides
for BDNF into the other eye (antisense +
BDNF). Solid symbols represent mean CBI 6
S.E.; each open symbol represents CBI of
a single animal. Imbalance of BDNF levels
between the two eyes causes a statistically
significant OD shift (t test, p < 0.001). Shaded
region represents the CBI range of normal
animals.
(B) Cumulative distributions of the OD score in
the treated animals. Statistical testing con-
firms that the combined treatment with anti-
sense in one eye and BDNF in the other eye af-
fects eye preference of cortical neurons (K-S
test, p < 0.001).
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Figure 4. Functional Properties of RGCs and
Geniculate Neurons Are Not Affected by Ma-
nipulation of Retinal BDNF Levels
(A–C) RGC spiking activity recorded in the op-
tic tract in response to a light flash. A repre-
sentative ON-OFF response is shown in (A).
The bar underneath the peristimulus time his-
tograms (PSTH) represents flash duration. (B
and C) Box charts showing RGC spontaneous
discharge and average response to light in
normal uninjected rats (norm) and rats in-
jected with sense oligonucleotides (sense),
antisense oligonucleotides (antisense), and
exogenous BDNF (1–2 days and 2 hr after
treatment). Mean spontaneous firing rate
was quantified in the 3–5 s interval of each
PSTH. Response was taken as the average
spike activity in the 0–2.5 s interval, including
both the ON and the OFF response activity in
each graph. Statistical analysis demonstrates
that baseline activity and average response
are superimposable among the groups (one-
way ANOVA on ranks, p > 0.05).
(D) Representative response of a geniculate
cell to the presentation of a sinusoidal grating
(spatial frequency 0.07 cycles/deg, contrast
80%, temporal frequency of alternation 4 Hz).
The cell shown here exhibits nonlinear spatial
summation.
(E–G) Box plots summarizing the distribution
of the peak-to-baseline ratio (E), spontaneous
discharge (F), and interspike intervals (G) for
cells recorded in the geniculate of normal
rats and rats injected with sense oligonucleo-
tides, antisense oligonucleotides, or exoge-
nous BDNF. For each box chart, the central
horizontal line is the median value, and the
other two horizontal lines are 25% and 75%
interquartile ranges; the open square is the
mean value, and the vertical bars are the stan-
dard deviations. No statistical differences can
be detected among the experimental groups
(one-way ANOVA on ranks, p > 0.05).or an alternating sinusoidal grating) (see Figure 4D) and
the rate of spontaneous discharge. We found that peak-
to-baseline ratios were identical in sense, antisense, or
BDNF-treated animals as shown in Figure 4E (one-way
ANOVA on ranks, p = 0.13). Spontaneous discharge
was also superimposable among the experimental
groups (one-way ANOVA on ranks, p = 0.13) (Figure 4F).
Analysis of interspike interval distributions revealed no
differences in the temporal patterning of the discharge
between the various groups (one-way ANOVA on ranks,
p = 0.15) (Figure 4G). Thus, our analysis revealed no sig-
nificant differences in visual responses and baseline ac-
tivity among the different injection conditions.
To further determine stimulus selectivity after the var-
ious treatments, we recorded responses of geniculate
cells to sinusoidal gratings alternating at different tem-
poral frequencies (see Figure 4D). No differences in the
shape of the temporal frequency tuning curve were ob-
servedamong the experimentalgroups (two-way ANOVA,
p > 0.05). Most units responded best to temporal fre-
quencies around 4 Hz and showed a drop off in response
amplitude at higher and lower temporal frequencies
(data not shown). We also found that the spatial fre-
quency tuning characteristics of geniculate cells was
similar in all experimental groups. Most cells showedmaximal responses at 0.07 cycles/deg and sharp de-
clines in sensitivity at higher spatial frequency with cut
offs in the order of 0.35 cycles/deg. Finally, contrast
response characteristics were also superimposable
among the groups (data not shown). Overall, we con-
clude that the different injection conditions produced
no detectable differences in input activity that might im-
pact on OD at the cortical level.
Discussion
Our results show for the first time that OD plasticity in the
primary visual cortex is influenced by BDNF expression
in the retina. Indeed, we demonstrate that monocular
eyelid suture decreases BDNF levels in the deprived
eye and that a compensation of this BDNF imbalance,
via BDNF injections into the deprived eye or antisense
injections into the open eye, counteracts the effects of
MD. Modulation of retinal BDNF levels induces a small
OD shift also in normally reared animals. These plastic
effects are not accompanied by measurable alterations
in electrical activity in the afferent pathway to the cortex,
suggesting that some aspect of BDNF signaling other
than input activity is important.
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2123Lack of visual experience during a developmental
critical period is well known to alter the anatomical
and physiological properties of the visual cortex [1].
The mechanisms underlying these plastic events are
still debated, but the general consensus is that their lo-
cus is cortical. In particular, the retina has long been
considered virtually unaffected by visual deprivation. In-
deed, early experiments performed mainly on the cat
visual system found no discernible effects of visual dep-
rivation on either retinal morphology or physiology [2,
13, 14]. These findings have suggested a central origin
for the functional abnormalities of visually deprived ani-
mals. More recently, however, it has been possible to
detect alterations of retinal circuitry in animals deprived
of visual experience [5]. Specifically, the developmental
segregation of RGC dendrites into ON or OFF sublamina
and the emergence of pure ON versus OFF responses
are blocked by dark rearing [5]. Whether these altera-
tions at the retinal level contribute to experience-depen-
dent changes in primary visual cortex remains un-
known. Neurochemical alterations in the retina have
also been reported after manipulation of visual experi-
ence. Both BDNF mRNA and protein levels are in-
creased by rearing rats in constant light and decreased
by dark rearing [6]. We have shown here that deprivation
of patterned stimulation by MD is sufficient to halve
BDNF protein levels in the sutured retina. Our findings
are in keeping with those of Seki and colleagues [7]
who reported a reduction of BDNF expression in the ret-
ina of rats monocularly deprived for two weeks after eye
opening. To test whether altering retinal BDNF levels
may have an impact on the outcome of MD, we injected
recombinant BDNF into the deprived eye or antisense
oligonucleotides for BDNF into the open eye, and we
measured the OD shift after 3–4 days of MD. As a result
of both treatments, the effect of MD was to a large ex-
tent prevented.
Methodological Considerations
Our measurements of radiolabeled BDNF after intravi-
treal delivery of microgram amounts indicate that the
eye retains tens of nanograms of BDNF protein 24 hr af-
ter injection (see Figure 1B). Because endogenous
BDNF amounts in the postnatal rodent retina are in the
order of a few picograms (Figure 1A and [15]), BDNF lev-
els were approximately 10,000-fold higher in the injected
retina than normal. Thus, if an imbalance of BDNF levels
between the two eyes controls eye preference, one
might expect a paradoxical shift in OD in favor of the de-
prived, BDNF-injected eye in monocularly deprived ani-
mals. However, we observed only a compensation of the
OD shift after BDNF administration to the sutured eye
but not an ‘‘overcorrection.’’ This finding can be ex-
plained by the fact that uptake and anterograde trans-
port of exogenous BDNF are largely receptor mediated
and saturate with much lower amounts of injected
BDNF [16, 17]. Indeed, only a few picograms of BDNF
are anterogradely transported to the dLGN after injec-
tion of 0.5–1 mg into the eye (Figure 1C). Thus, saturation
of uptake/transport mechanisms effectively limits the
amount of exogenous BDNF that is available to RGCs
and geniculate neurons.
To reduce BDNF expression in the retina, we used in-
jection of antisense oligonucleotides that selectivelytarget BDNF mRNA but not other neurotrophins as
shown by BLAST analysis. This antisense strategy effi-
ciently blocks BDNF synthesis and anterograde trans-
port along the optic nerve (Figures 1D–1E and [9]). We
have demonstrated in a preceding paper that intravitreal
delivery of these antisense oligonucleotides decreases
retinal BDNF levels with no adverse effect on RGC sur-
vival, soma size, and dendritic arborisation [9]. Intraocu-
lar injection of sense oligonucleotides had no effect on
the eye preference of cortical neurons, ruling out any
toxic effect of the oligonucleotide treatment per se.
The finding that raising BDNF levels via exogenous ad-
ministration produces OD changes that are opposite to
those obtained with knockdown of BDNF further sup-
ports the specificity of our antisense approach.
Mechanisms of BDNF Action
BDNF has been reported to exert a rapid and long-
lasting modulation of synaptic transmission in several
studies [18, 19]. Accordingly, one possible explanation
of our results is that retinal BDNF controls OD by modu-
lating the level and/or pattern of neuronal activity along
the afferent pathway to the cortex. Retina-derived BDNF
might affect electrical activity both at the retinal and ge-
niculate level because of its anterograde actions. There-
fore, we have analyzed spike activity of both RGCs and
geniculate neurons in rats treated with exogenous BDNF
and antisense oligonucleotides. Recordings were per-
formed either within 2 hr or 1–2 days after injection of
BDNF to evaluate acute and long-term effects of the
neurotrophin on neuronal firing and 3–4 days after re-
peated delivery of antisense oligonucleotides to assess
cell excitability at the time of maximal depletion of en-
dogenous BDNF. Indeed, since antisense oligonucleoti-
des only prevent translation of BDNF mRNA, significant
reductions of BDNF protein levels are likely to require
several hours after antisense delivery, consistent with
previous data [9, 20, 21]. Our data indicate that input
activity is not affected by manipulation of retinal BDNF
levels. Indeed, quantification of baseline activity and
response properties of RGCs and geniculate cells
revealed no significant differences with respect to the
control animals. It is worth noting that exactly the
same kind of analysis readily detected activity changes
when much greater amounts of BDNF were adminis-
tered into the cortex [22]. Thus, effects of retinal BDNF
on OD are not secondary to discernible changes in input
activity.
Although the experiments reported here indicate that
at least part of the MD effect in the cortex can be attrib-
uted to changes of BDNF concentration in the eye, they
do not provide a mechanism by which retinal BDNF can
affect cortical plasticity. One first hypothesis is that
BDNF produces changes in retinal circuitry that second-
arily affect cortical OD. As discussed above, whether
retinal alterations can contribute to cortical plasticity
has not been demonstrated yet. A second hypothesis
is that BDNF influences plasticity via an anterograde ef-
fect from the eye. This anterograde action is supported
by our data demonstrating robust accumulation of
BDNF in the geniculate after eye injections (see Fig-
ure 1C). Indeed, it is known that anterograde BDNF
activates signal transduction cascades in geniculocor-
tical cells and that these signaling pathways influence
Current Biology
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phic action of anterograde BDNF on thalamic cells
may allow sparing of geniculocortical arbors and synap-
tic contacts from the deprived visual input. Indeed, there
is evidence in the literature that application of a neuro-
trophic factor to the soma can influence axonal arboriza-
tion and synapse formation [25]. In addition, BDNF re-
leased at the thalamic level might regulate synaptic
transmission at geniculo-cortical synapses. It has been
previously shown that stimulation of the cell body with
a growth factor anterogradely regulates release proba-
bility at the synaptic terminal [23, 26]. A third hypothesis
could be that retina-derived BDNF is transferred by
transcytosis to cortical neurons. We have addressed
this possibility by injection of iodinated BDNF into the
eye followed by g counting and autoradiography of cor-
tical tissue, and we have found that the transport of ex-
ogenous BDNF from the retina to the cortex is below the
limit of detection (see Figure S1). The minimal amount of
cortically transported BDNF, which might have escaped
detection, is unlikely to have any significant physiologi-
cal effect given the relatively high levels of endogenous
BDNF expression in the cortex. Thus, retina-derived
BDNF most likely affects cortical OD plasticity by acting
at the level of the geniculate neurons.
Conclusion
We have provided evidence that BDNF produced in the
retina contributes to plasticity in the visual cortex after
monocular deprivation. These data challenge the com-
monly held view that OD plasticity is exclusively attrib-
uted to cortical mechanisms.
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a figure and can be found with this article online at http://www.
current-biology.com/cgi/content/full/15/23/2119/DC1/.
Acknowledgments
This work was supported by Fondo per Gli Investimenti della Ricerca
di Base project RBNE 01R7H4-002, by Cofinanziamento Progetti di
Ricerca di Interesse Nazionale 2001 and 2002, and by National Insti-
tutes of Health grant EY 12841 (to C.S.v.B.). The authors thank Am-
gen for kindly supplying recombinant human BDNF and Qiao Yan
and Robert Rush for the generous supply of antibodies. We are
grateful to E. Putignano, A. Viegi, C. Rossi, and S. Chierzi for partici-
pating in some experiments. We thank G.M. Ratto, N. Berardi, and
T. Pizzorusso for critical reading of this manuscript and C. Orsini,
G.C. Cappagli, and S. Vella for invaluable technical assistance.
Received: March 8, 2005
Revised: September 12, 2005
Accepted: October 13, 2005
Published: December 5, 2005
References
1. Hensch, T.K. (2004). Critical period regulation. Annu. Rev. Neu-
rosci. 27, 549–579.
2. Baro, J.A., Lehmkuhle, S., and Kratz, K.E. (1990). Electroretino-
grams and visual evoked potentials in long-term monocularly
deprived cats. Invest. Ophthalmol. Vis. Sci. 31, 1405–1409.
3. Sherman, S.M., and Spear, P.D. (1982). Organization of visual
pathways in normal and visually deprived cats. Physiol. Rev.
62, 738–855.
4. Berardi, N., Pizzorusso, T., Ratto, G.M., and Maffei, L. (2003).
Molecular basis of plasticity in the visual cortex. Trends Neuro-
sci. 26, 369–378.5. Tian, N., and Copenhagen, D.R. (2003). Visual stimulation is re-
quired for refinement of ON and OFF pathways in postnatal ret-
ina. Neuron 39, 85–96.
6. Pollock, G.S., Vernon, E., Forbes, M.E., Yan, Q., Ma, Y.T., Hsieh,
T., Robichon, R., Frost, D.O., and Johnson, J.E. (2001). Effects of
early visual experience and diurnal rhythms on BDNF mRNA and
protein levels in the visual system, hippocampus, and cerebel-
lum. J. Neurosci. 21, 3923–3931.
7. Seki, M., Nawa, H., Fukuchi, T., Abe, H., and Takei, N. (2003).
BDNF is upregulated by postnatal development and visual ex-
perience: quantitative and immunohistochemical analyses of
BDNF in the rat retina. Invest. Ophthalmol. Vis. Sci. 44, 3211–
3218.
8. Caleo, M., Menna, E., Chierzi, S., Cenni, M.C., and Maffei, L.
(2000). Brain-derived neurotrophic factor is an anterograde sur-
vival factor in the rat visual system. Curr. Biol. 10, 1155–1161.
9. Menna, E., Cenni, M.C., Naska, S., and Maffei, L. (2003). The
anterogradely transported BDNF promotes retinal axon remod-
eling during eye specific segregation within the LGN. Mol. Cell.
Neurosci. 24, 972–983.
10. von Bartheld, C.S., Wang, X., and Butowt, R. (2001). Antero-
grade axonal transport, transcytosis, and recycling of neuro-
trophic factors: the concept of trophic currencies in neural net-
works. Mol. Neurobiol. 24, 1–28.
11. Pizzorusso, T., Medini, P., Berardi, N., Chierzi, S., Fawcett, J.W.,
and Maffei, L. (2002). Reactivation of ocular dominance plastic-
ity in the adult visual cortex. Science 298, 1248–1251.
12. Rittenhouse, C.D., Shouval, H.Z., Paradiso, M.A., and Bear, M.F.
(1999). Monocular deprivation induces homosynaptic long-term
depression in visual cortex. Nature 397, 347–350.
13. Sherman, S.M., and Stone, J. (1973). Physiological normality of
the retinal in visually deprived cats. Brain Res. 60, 224–230.
14. Leventhal, A.G., and Hirsch, H.V. (1983). Effects of visual depri-
vation upon the morphology of retinal ganglion cells projecting
to the dorsal lateral geniculate nucleus of the cat. J. Neurosci.
3, 332–344.
15. Ma, Y.T., Hsieh, T., Forbes, M.E., Johnson, J.E., and Frost, D.O.
(1998). BDNF injected into the superior colliculus reduces devel-
opmental retinal ganglion cell death. J. Neurosci. 18, 2097–2107.
16. Caleo, M., Medini, P., von Bartheld, C.S., and Maffei, L. (2003).
Provision of brain-derived neurotrophic factor via anterograde
transport from the eye preserves the physiological responses
of axotomized geniculate neurons. J. Neurosci. 23, 287–296.
17. Butowt, R., and von Bartheld, C.S. (2005). Anterograde axonal
transport of BDNF and NT-3 by retinal ganglion cells: roles of
neurotrophin receptors. Mol. Cell. Neurosci. 29, 11–25.
18. Kafitz, K.W., Rose, C.R., Thoenen, H., and Konnerth, A. (1999).
Neurotrophin-evoked rapid excitation through TrkB receptors.
Nature 401, 918–921.
19. Poo, M.M. (2001). Neurotrophins as synaptic modulators. Nat.
Rev. Neurosci. 2, 24–32.
20. Wagner, R.W. (1994). Gene inhibition using antisense oligode-
oxynucleotides. Nature 372, 333–335.
21. Rickman, D.W., and Rickman, C.B. (1996). Suppression of trkB
expression by antisense oligonucleotides alters a neuronal phe-
notype in the rod pathway of the developing rat retina. Proc.
Natl. Acad. Sci. USA 93, 12564–12569.
22. Lodovichi, C., Berardi, N., Pizzorusso, T., and Maffei, L. (2000).
Effects of neurotrophins on cortical plasticity: same or different?
J. Neurosci. 20, 2155–2165.
23. Caleo, M., and Cenni, M.C. (2004). Anterograde transport of neu-
rotrophic factors: possible therapeutic implications. Mol. Neuro-
biol. 29, 179–196.
24. von Bartheld, C.S. (2004). Axonal transport and neuronal trans-
cytosis of trophic factors, tracers, and pathogens. J. Neurobiol.
58, 295–314.
25. Conner, J.M., Darracq, M.A., Roberts, J., and Tuszynski, M.H.
(2001). Nontropic actions of neurotrophins: subcortical nerve
growth factor gene delivery reverses age-related degeneration
of primate cortical cholinergic innervation. Proc. Natl. Acad.
Sci. USA 98, 1941–1946.
26. Stoop, R., and Poo, M.M. (1995). Potentiation of transmitter re-
lease by ciliary neurotrophic factor requires somatic signaling.
Science 267, 695–699.
